000 01544 a2200397 4500
005 20250518015832.0
264 0 _c20200218
008 202002s 0 0 eng d
022 _a1365-2249
024 7 _a10.1111/cei.13260
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRodríguez-Perea, A L
245 0 0 _aHigh concentrations of atorvastatin reduce in-vitro function of conventional T and regulatory T cells.
_h[electronic resource]
260 _bClinical and experimental immunology
_c05 2019
300 _a237-248 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntigens, CD
_xmetabolism
650 0 4 _aAtorvastatin
_xpharmacology
650 0 4 _aCTLA-4 Antigen
_xmetabolism
650 0 4 _aCells, Cultured
650 0 4 _aCytokines
_xmetabolism
650 0 4 _aFlow Cytometry
_xmethods
650 0 4 _aForkhead Transcription Factors
_xmetabolism
650 0 4 _aHumans
650 0 4 _aInterleukin-2
_xmetabolism
650 0 4 _aLeukocyte Common Antigens
_xmetabolism
650 0 4 _aLeukocytes, Mononuclear
_xdrug effects
650 0 4 _aProgrammed Cell Death 1 Receptor
_xmetabolism
650 0 4 _aReceptors, CCR7
_xmetabolism
650 0 4 _aT-Lymphocytes, Regulatory
_xdrug effects
650 0 4 _aTumor Necrosis Factor-alpha
_xmetabolism
700 1 _aRojas, M
700 1 _aVelilla-Hernández, P A
773 0 _tClinical and experimental immunology
_gvol. 196
_gno. 2
_gp. 237-248
856 4 0 _uhttps://doi.org/10.1111/cei.13260
_zAvailable from publisher's website
999 _c29249379
_d29249379